Publications

Psoriasin (S100A7) is increased in serum of patients with moderate to severe psoriasis  (2020)

Authors:
Maurelli, M; Gisondi, P; Danese, E; Gelati, M; Papagrigoraki, A; Del Giglio, M; Lippi, G; Girolomoni, G
Title:
Psoriasin (S100A7) is increased in serum of patients with moderate to severe psoriasis
Year:
2020
Type of item:
Articolo in Rivista
Tipologia ANVUR:
Articolo su rivista
Language:
Inglese
Format:
A Stampa
Referee:
Name of journal:
British Journal of Dermatology
ISSN of journal:
0007-0963
N° Volume:
182
Number or Folder:
6
Page numbers:
1502-1503
Keyword:
S100A7; psoriasin; psoriasis
Short description of contents:
Psoriasis is a chronic immune-mediated inflammatory disease affecting 2-3% of Caucasian population. Several inflammatory mediators in patient samples have been associated with psoriasis and its comorbidities. Psoriasin (S100A7), a proinflammatory protein belonging to the S100 family of small calcium-binding proteins, is produced by epidermal keratinocytes and peripheral leukocytes and is significantly overexpressed in psoriasis.
Web page:
https://doi.org/10.1111/bjd.18807
Product ID:
111510
Handle IRIS:
11562/1008527
Last Modified:
December 1, 2022
Bibliographic citation:
Maurelli, M; Gisondi, P; Danese, E; Gelati, M; Papagrigoraki, A; Del Giglio, M; Lippi, G; Girolomoni, G, Psoriasin (S100A7) is increased in serum of patients with moderate to severe psoriasis «British Journal of Dermatology» , vol. 182 , n. 62020pp. 1502-1503

Consulta la scheda completa presente nel repository istituzionale della Ricerca di Ateneo IRIS

<<back

Activities

Research facilities

Share